Bengaluru and Singapore-based Heart Health-AI firm Tricog has raised $8.5 million in a Series B2 funding round led by Japan-based Omron Healthcare and Sony Innovation Fund. The round also saw participation from Existing investors UTEC - The University of Tokyo Edge Capital, Japan, Inventus Partners LLP and SG Innovate, Singapore.
With this, The company has raised a total funding of $3 million. Tricog said its AI platform is backed by medical experts and has touched the lives of more than 12 Million patients globally, enabling half a million patients added to the care pathway due to critical diseases.
The company aims to make a cardiac diagnosis and management accessible and affordable by deepening partnerships with government and large private healthcare networks and building state-of-the-art technology for next-generation products, enabling wider reach in patient populations and disease conditions.
Founded in 2015 by Dr Charit Bhograj, Dr Zainul Charbiwala, and Dr Udayan Dasgupta, Tricog specialises in the preventive diagnosis and care with a vision to accelerate cardiac care globally.
The company aims to help doctors save more lives by providing a system for fast and accurate diagnosis and management of heart disease powered by AI and medical experts.
According to the company's statement, The platform has been deployed in over 5000 Cath Labs, Hospitals, Clinics and Diagnostic Centres to help diagnose and manage patients with critical cardiac diseases, including heart attacks. The platform is deployed across five state governments and numerous private healthcare networks, significantly reducing mortality and morbidity.
Statements:
Dr Charit Bhograj, Founder & CEO of Tricog Health, said, "The last five years have witnessed tremendous advancements in our AI and technology platform that have allowed us to serve millions of patients across multiple continents. With this round, we are committed to expanding our reach to Asia and Africa and our footprint in the US healthcare market. In addition, our strategic partnerships will allow us, for the first time, to address the needs of heart patients at home, the direction where healthcare will be."
Tetsuya Yamada, Head, OMRON Healthcare India, “With this funding, OMRON Healthcare, the leading player in the home healthcare monitoring segment, aims to create value in the cardiovascular space by enabling people to detect the risk of the heart diseases early and prevent aggravation by using OMRON’s home ECG & BP recording device, Tricog's AI, and telemedicine & consultation services by cardiologists.”
Noriaki Sakamoto, Partner and Board Director, UTEC, Japan, said, “Tricog is a stellar example of the transformative potential of AI and Doctors working together to tackle a large global unmet need. As lead investors of Tricog since 2018, we at UTEC take immense pride in Tricog’s evolution from an India-focused ECG product into a full-stack cardiac diagnosis platform and are honored to foster their alliance with top-tier Japanese Health-tech giants such as Omron and Sony to profoundly impact millions of lives worldwide.”
Hsien-Hui Tong, Executive Director, Investments, SGInnovate, said, “SGInnovate was an early partner of Tricog's and is delighted to see them continue to grow as a company. Their predictive models are filling a vast unmet need in the remote healthcare space, and we look forward to supporting their expansion into more markets across Asia and Africa.”
Also Read: